2.6 Role of the funding source
The study was overseen by the Hokuriku Clinical Research Supporting Center. The data centre of the innovative clinical research centre of Kanazawa University managed and handled all data. The statistical department of the centre was involved in the analysis of data. All authors had access to study results, and the lead author takes responsibility for the accuracy and completeness of the data reported. The lead author had the final decision to submit the publication.
This study was supported by a Grant‐in‐Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS KAKENHI) Grant number 26893095. Although the study drug was provided by the Sanwa Kagaku Kenkyusho Co., Ltd, the company had no role in the design of the study; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the article for publication.
Hi Rad,
The authors of this study have reported no conflict of interest, although they did receive some funding for the study & drugs supplied, funding source statement above.
Not worried about any of this & an interesting read. Thanks @Flotsam for posting.
- Forums
- ASX - By Stock
- DXB
- General Discussion
General Discussion, page-48
-
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
47.5¢ |
Change
-0.015(3.06%) |
Mkt cap ! $261.3M |
Open | High | Low | Value | Volume |
49.5¢ | 49.5¢ | 46.5¢ | $2.742M | 5.746M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 158396 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 162500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 66789 | 0.480 |
3 | 170500 | 0.475 |
7 | 158801 | 0.470 |
4 | 77577 | 0.465 |
7 | 192700 | 0.460 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 6191 | 4 |
0.480 | 132755 | 2 |
0.490 | 12211 | 1 |
0.495 | 186172 | 6 |
0.500 | 165847 | 5 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online